Over years of cancer drug research, Genentech Inc. has kept a keen watch on patients: how they respond to drugs in a clinical trial, for example, or what patients need in a next-generation drug.
Yet even as the South San Francisco-based biotech unit of Swiss drug giant Roche developed some of the best-selling and effective cancer drugs — Avastin and Herceptin among them — it heard from patients that the medications themselves were not enough.
Breast cancer patients, in particular, wanted to feel connected to others going through treatment. They wanted more support and resources.
Help employers find you! Check out all the jobs and post your resume.
